• McClellan, K. J., & Markham, A. (1998). Telmisartan. Drugs, 56(6). https://pubmed.ncbi.nlm.nih.gov/9878991/
• Sharpe, M., Jarvis, B., & Goa, K. L. (2001). Telmisartan: a review of its use in hypertension. Drugs, 61(10), 1501-1529. https://pubmed.ncbi.nlm.nih.gov/11558835/
• Kuschnir, E., Acuña, E., Sevilla, D., Vasquez, J., Bendersky, M., Resk, J., & Glazer, R. (1996). Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. Clinical therapeutics, 18(6), 1213-1224. https://pubmed.ncbi.nlm.nih.gov/9001838/
• Abernethy, D. R. (1989). The pharmacokinetic profile of amlodipine. American heart journal, 118(5), 1100-1103. https://pubmed.ncbi.nlm.nih.gov/2530866/
• Pareek, A. K., Messerli, F. H., Chandurkar, N. B., Dharmadhikari, S. K., Godbole, A. V., Kshirsagar, P. P., ... & Kumbla, M. M. (2016). Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. Journal of the American College of Cardiology, 67(4), 379-389. https://pubmed.ncbi.nlm.nih.gov/26821625/